N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141113 |
| CAS No | NA |
| Mol.F. | C16H18N4O |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141114 |
| CAS No | NA |
| Mol.F. | C16H14N4O2 |
| Mol.Wt. | 294.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141115 |
| CAS No | NA |
| Mol.F. | C5H3N5OS |
| Mol.Wt. | 181.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141116 |
| CAS No | NA |
| Mol.F. | C8H16N2OS |
| Mol.Wt. | 188.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141117 |
| CAS No | NA |
| Mol.F. | C9H16N2O3S |
| Mol.Wt. | 232.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141118 |
| CAS No | NA |
| Mol.F. | C9H15N3OS |
| Mol.Wt. | 213.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141119 |
| CAS No | NA |
| Mol.F. | C24H24N6O2 |
| Mol.Wt. | 428.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141120 |
| CAS No | NA |
| Mol.F. | C24H24N6O2 |
| Mol.Wt. | 428.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141110 |
| CAS No | NA |
| Mol.F. | C11H15N3O |
| Mol.Wt. | 205.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141111 |
| CAS No | NA |
| Mol.F. | C11H15N3O |
| Mol.Wt. | 205.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141121 |
| CAS No | NA |
| Mol.F. | C17H22N2O2 |
| Mol.Wt. | 286.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141122 |
| CAS No | NA |
| Mol.F. | C23H23N5O4 |
| Mol.Wt. | 433.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141123 |
| CAS No | NA |
| Mol.F. | C24H26F2N6O5 |
| Mol.Wt. | 516.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141124 |
| CAS No | NA |
| Mol.F. | C28H24F2N8O6S |
| Mol.Wt. | 638.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141125 |
| CAS No | NA |
| Mol.F. | C29H26F2N8O6S |
| Mol.Wt. | 652.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141126 |
| CAS No | NA |
| Mol.F. | C24H20BrFN6O3 |
| Mol.Wt. | 539.4 |
| INV STATUS | CUSTOM SYNTHESIS |